A recent article that appeared in the New York Times about DIY biology and biohacking, has sparked controversy and raises questions about biosecurity, and the regulation of synthetic biology.
Altering the genome, typically to better understand gene and protein function. This also paves the way for gene therapy.
Researchers at the RIKEN Center for Brain Science have discovered a mutation that can protect against Alzheimer’s disease in mice.
Researchers have slowed the growth of pancreatic cancer by harnessing CRISPR genome editing to remove key molecules implicated in its spread.
Researchers have developed a new technique for the powerful gene editing tool CRISPR to restore retinal function in mice afflicted by a degenerative retinal disease. This is the first time researchers have successfully applied CRISPR technology to a type of inherited disease known as a dominant disorder.
There are fears that CRISPR could be used by criminals to clear their names from forensic databases or evade detection, as access to the technique becomes more widely available.
The gene atlas enables a new functional view on how we study the human genome, and provides a tool that will change how we study and treat cancer and genetic disorders.
Researchers have discovered a way to greatly improve the accuracy of gene-editing technology by replacing the natural guide molecule it uses with a synthetic one called a bridged nucleic acid, or BNA.
Artificial human embryos could soon be on the horizon, but what will it mean? Well, arguably the potential of such a breakthrough could herald a new biological revolution.